ѧÊõÌÃÊ×Ò³ | ÎÄÏ×ÇóÖúÂÛÎÄ·¶ÎÄ | ÂÛÎÄÌâÄ¿ | ²Î¿¼ÎÄÏ× | ¿ªÌⱨ¸æ | ÂÛÎĸñʽ | ÕªÒªÌá¸Ù | ÂÛÎÄÖÂл | ÂÛÎIJéÖØ | ÂÛÎÄ´ð±ç | ÂÛÎÄ·¢±í | ÆÚ¿¯ÔÓÖ¾ | ÂÛÎÄд×÷ | ÂÛÎÄPPT
ѧÊõÌÃרҵÂÛÎÄѧϰƽ̨Äúµ±Ç°µÄλÖãºÑ§ÊõÌà > ÉúÎïѧÂÛÎÄ > »ùÒò¹¤³ÌÂÛÎÄ

ÖíÖ¬·¾ÐÔ×´¹ØÁªµÄ¹¦ÄÜ»ùÒòÑо¿½øÕ¹(2)

À´Ô´£ºÑ§ÊõÌà ×÷Õߣºº«ÀÏʦ
·¢²¼ÓÚ£º2015-12-11 ¹²4292×Ö

¡¡¡¡ÀûÓÃRT-PCR·¨¼ì²â6ÔÂÁä°Ëü¡¢³¤°×ºÍ³¤×°ËÔÓ½»ÖíºóÍȲ¿±ÈÄ¿Ó㼡¡¢ë賦¼¡ºÍÖº³¤É켡ÖÐFoxOl»ùÒòµÄ±í´ïÁ¿[32],½á¹û·¢ÏÖ£¬FoxOl»ùÒòÔÚ°ËüÖíºÍÔÓ½»×éºÏÖí¹Ç÷À¼¡Öеıí´ïÁ¿¾ùÏÔןßÓÚ³¤°×Öí£¬±íÃ÷FoxO1ºÜ¿ÉÄܶÔÖí¹Ç÷À¼¡µÄº¬Á¿½øÐиºµ÷¿Ø£¬´Ë»ùÒòºÜ¿ÉÄÜÊǵ¼Ö²»Í¬¾­¼ÃÀàÐÍÖí¼¡Èâ·¢Óý¹ý³Ì²úÉú²îÒìµÄÖ÷Òª»ùÒòÖ®Ò»[33],ͬʱ»¹·¢ÏÖÔÚÒÔIIbÐÍÏËάΪÖ÷µÄÖº³¤É켡Öбí´ï·á¶ÈÔ¶Ô¶¸ßÓÚÒÔIÐÍÏËάΪÖ÷µÄ±ÈÄ¿Ó㼡£¬±íÃ÷FoxOl»ùÒòµÄ±í´ïÓëIÐͼ¡ÏËάµÄº¬Á¿³É·´±È£¬FoxOl»ùÒòµ÷¿Ø²»Í¬¾­¼ÃÀàÐÍÖíÆ·ÖÖ¹Ç÷À¼¡µÄ·¢Óý¡£Í¬Ä꣬ÓÖÑо¿·¢ÏÖFoxOlºÍ³É¼¡·Ö»¯¿¹Ô­£¨myogenic differentiation anti-gen, MyoD£©»ùÒòmRNAµÄ±í´ïÔÚ²»Í¬¾­¼ÃÀàÐÍÖí¼¡Èâ·¢ÓýÖдæÔÚ¸ºÏà¹Ø£¬Ïà¹ØϵÊýΪ 0.728[34].ÀûÓÃRT-PCR¡¢Western blottingµÈ¼ì²âÔÚÖí³É¼¡Ï¸°û·Ö»¯¹ý³ÌÖÐ FoxO1 ÔçÆÚºÍÍíÆÚ MyoD ¼°¼¡Ï¸°ûÉú³ÉËØ£¨myogenin, MyoG£©µÄ±í´ï±ä»¯£¬½á¹û·¢ÏÖ£¬¾¡¹ÜFoxO1 mRNA±í´ïÁ¿ÏÔ×ÅÔö¼Ó£¬µ«×ܵ°°×Á¿±ä»¯²»ÏÔ×Å£¬ÏÔ×ÅÉϵ÷ÁËÆäÁ×Ëữˮƽ[35];ͬʱ£¬¸ß±í´ïFoxO1 µÄÖí³É¼¡Ï¸°ûÖУ¬MyoD µ°°×±ä»¯²»ÏÔ×Å£¬MyoGˮƽȴÃ÷ÏÔ½µµÍ£¬±íÃ÷Öí³É¼¡Ï¸°ûµÄ·Ö»¯Ê±¼äÍƳټ°±»ÒÖÖÆ·Ö»¯ºÜ¿ÉÄÜÊÇÒòΪ FoxO1 ×÷ÓõĽá¹û¡£FoxO1ÔÚ180ÈÕÁä´ó°×Öí±ÈÄ¿Ó㼡¡¢Öº³¤É켡¡¢ë賦¼¡ºÍ±³×¼¡Öеıí´ï²îÒì¾ù²»ÏÔ×Å£¬Æäµ°°×±í´ïÓë MyHC ¸÷ÑÇÐͳÊÏÔ×ÅÏà¹Ø£¬ÓÃÇàùËØ£¨wort-mannin£©´¦ÀíÔ­´úÅàÑøµÄÖí¹Ç÷À¼¡³É¼¡Ï¸°ûµÄµÚ3ºÍ5Ììʱ£¬FoxO1µ°°×ÓëMyHC I¡¢MyHC IIaºÍ¼¡Ï¸°ûÔöÇ¿Òò×Ó 2c£¨MEF2c£©±í´ï¾ù³ÊÏÔןºÏà¹Ø[36],±íÃ÷FoxO1ºÜ¿ÉÄÜÊÇͨ¹ýÒÖÖÆMyHC IµÄ±í´ïÀ´µ÷¿Ø¼¡ÏËάÀàÐÍ¡£FoxO1ºÜ¿ÉÄÜÊÇͨ¹ýÒÖÖÆÉñ¾­¸Æµ°°×£¨cali-cineurinm, CaN£©/»î»¯Tϸ°ûºËÒò×Ó£¨nuclear fac-tor of activated T cells, NEAT£©ÐźÅͨ·»òCaN/MEF2ÐźÅͨ·¶ÔIÐͼ¡ÏËάµÄ±í´ï½øÐиºµ÷¿Ø[37];2¡¢5ÔÂÁäÃñÖíºÍ³¤°×ÖíµÄÉöÖÜÖ¬·¾ÖÐFoxOl»ùÒò±í´ïÁ¿¼«ÏÔןßÓÚ1¡¢6¡¢8ÔÂÁ䣬²¢·¢ÏÖFoxO1¿ÉÄÜͨ¹ý ÒÖ ÖÆ PPARγ¡¢ CCAAT Çø/Ôö Ç¿ ×Ó ½á ºÏ µ° °× ᣨCCAAT/ enhancer binding protein ᣬ C/EBPᣩ»ùÒòµÄ±í´ïÀ´¼õÉÙÖ¬·¾³Á»ý[38].

¡¡¡¡4 ¸Æµ°°×øÒÖÖƵ°°×£¨Calpastatin, CAST£©»ùÒò

¡¡¡¡¸Æµ°°×øÒÖÖƵ°°×£¨calpastatin, CAST£©»ùÒòÊÇÒ»ÖÖÌض¨µÄ¡¢ÄÚÔ´ÐԵġ¢Ðè¸Æ¼¤»îµÄµ°°×øÒÖÖƼÁ£¬±»¶¨Î»ÓÚÖíµÄ2ºÅȾɫÌåÉÏ[39].CAST»ùÒòÓ뼡ÈâÄ۶ȴæÔÚ¼«Æä½ôÃܵÄÁªÏµ£¬Æä²úÎï¶ÔÓÚ¼¡ÈâÉú³¤¹ý³ÌÖе°°×ÖʵĸüоßÓÐÖØÒª×÷Óá£ÔÚϸ°ûÄÚÆÕ±é´æÔÚ×ÅÐè¸Æµ°°×ø£¨calpain£©µÄµ°°×Ë®½âϵͳ£¬´óÁ¿²ÎÓëµ½Éú³¤ºÍ´úл¹ý³Ì¡£¸Æµ°°×øϵͳÖ÷Òª°üÀ¨¸Æµ°°×øºÍ¸Æµ°°×øÒÖÖƵ°°×¡£¸Æµ°°×ø¸ù¾ÝÆä±íÏÖ°ë×î¸ß»îÐÔËùÐèµÄ Ca2+Ũ¶È·ÖΪ 2 À࣬¸Æµ°°×ø 1£¨u-calpain£©ºÍ¸Æµ°°×ø2£¨m-calpain£©¡£»îÌåÍÀÔ׺ó½ÏµÍŨ¶ÈµÄCa2+¾Í¿ÉÒÔ¼¤»îu-calpain,ʹÆä±íÏÖ³öµ°°×Ë®½âø»îÐÔ¡£Èç¹û¸½½üÓÐ CAST,¾Í¿ÉѸËÙÓëu-calpain½áºÏ£¬ÒÖÖƵ°°×øµÄ»îÐÔ£¬´Ó¶øÒÖÖƼ¡ÈâÄÚµ°°×ÖʵĽµ½â£¬´Ù½øµ°°×Öʵĺϳɣ¬Ìá¸ß¼¡Ï¸°ûÉú³¤ËÙ¶È[40].ÖíÈâµÄÄÛ¶ÈÓëCAST/u-calpainµÄ»îÐÔ±ÈÖµÓÐÃÜÇеÄÁªÏµ£¬»îÐÔ±ÈÖµÔ½´ó£¬CASTµÄÁ¿Ïà¶ÔÔ½´ó£¬¸Æµ°°×øÒÖÖƵ°°×¶Ô¸Æµ°°×øµÄÒÖÖÆ×÷ÓÃԽǿ£¬ÈâµÄÄÛ¶ÈÔ½ºÃ[41].¶Ô125Í·ÔÓ½»Öí½øÐжà̬λµãÑо¿²¢·ÖÎöÆä¶ÔÖíµÄÈâÖʺͱ³±ìµÄÓ°Ïìʱ·¢ÏÖ£¬ÆäÖÐA¡¢B 2¸öλµã¾ù¶Ô¼¡ÄÚÖ¬·¾º¬Á¿ÓÐÏÔ×ÅÓ°Ï죬B¡¢C¡¢D 3¸öλµã¾ù¶Ô±³±ìºñÓÐÏÔ×ÅÓ°Ïì[42].¶Ô3¸öÖíÆ·ÖָƵ°°×øÒÖÖƵ°°×»ùÒò¶à̬ÐÔ½øÐÐÁËÑо¿£¬½á¹û·¢ÏָƵ°°×øÒÖÖƵ°°×»ùÒòµÄÒ»¶¨»ùÒòÐÍÓëÖíÈâµÄÄ۶ȴæÔÚÏà¹ØÐÔ¡£ÓÉ´Ë¿´À´£¬¸Æµ°°×øÒÖÖƵ°°×Ö÷Ҫͨ¹ýÓ°ÏìÖíÈâµÄÄÛ¶ÈÀ´¸Ä±äÖíÈâµÄÈâÖÊÐÔ×´[43].

¡¡¡¡5 ´ÙºÚ¼¤ËØƤÖÊËØ 4 ÊÜÌ壨Melanocortin-4 receptor,MC4R£©»ùÒò

¡¡¡¡´ÙºÚ¼¤ËØƤÖÊËØ4ÊÜÌ壨melanocortin- 4 re-ceptor, MC4R£©£¬ÓÉ332¸ö°±»ùËá²Ð»ù×é³É£¬ÊÇ¿çĤG-µ°°×żÁªÊÜÌ壨G-protein coupled receptors,GPCRs£©³¬¼Ò×åµÄ³ÉÔ±Ö®Ò»[44].MC4RÄܹ»Í¨¹ýÖÐÊàÉñ¾­ÏµÍ³µ÷½ÚÌåÖØ£¬Ö÷Òª±íÏÖΪÒÖÖÆÉãʳ£¬µ¼ÖÂѪÌÇ¡¢ÒȵºËغÍÊÝËØˮƽ½µµÍ£¬´Ó¶ø¼õÉÙÌåÖ¬¡¢½µµÍÌåÖØ£¬ÔÚ¶¯ÎïµÄÌåÖØ¡¢ÄÜÁ¿ÎÈ̬ºÍ²ÉʳÁ¿µÄµ÷¿ØÖоßÓÐÖØÒª×÷ÓÃ[45].Öí MC4R »ùÒòλÓÚ 1 ºÅȾɫÌåq22-27 ´¦£¬ÓëÖí 1 ºÅȾɫÌåÉϵÄÊý¸ö±ê¼ÇÃ÷ÏÔÁ¬Ëø£¬ÓÃÁ½µãÁ¬Ëø·ÖÎöµÃµ½µÄÁ½¸öÀëMC4R»ùÒò×î½üµÄÁ¬ Ëø ±ê ¼Ç ÊÇ SO3113£¨0, 17.76£©ºÍ S0082£¨0.05,14.74£©[46].

¡¡¡¡MC4R»ùÒòÐÍÓë±³±ìºñºÍÉú³¤ÂÊÒÔ¼°²ÉʳÁ¿³ÊÇ¿Ïà¹Ø£¬AA»ùÒòÐͱ³±ì±ÈBB»ùÒòÐͱ¡9%,BB»ùÒòÐͱÈAA»ùÒòÐÍÈÕÔöÖظß37 g/d,ÇÒ²îÒìÏÔ×Å[47].²»Í¬µÄMC4R»ùÒòÐͼäÈâÖÊÖ¸Êý¡¢×îºóÀ߹Ǵ¦±³±ìºñ¡¢Ñü²¿±³±ìºñ¡¢Æ½¾ù±³±ìºñ¡¢Æ½¾ùÈÕÔöÖØ¡¢¼¡ÈâÖÐÈéËáµÄ¼¯ÖвîÒìÏÔ×Å[48].ÖíMC4R»ùÒòµÚ7¿çĤ½á¹¹¹¦ÄÜÇøÓòµÄÒ»¸ö¸ß¶È±£ÊØÇø´æÔÚG-A´íÒåÍ»±ä£¬²úÉúTaqIøÇÐλµãµÄ¸Ä±ä£¬Õâһͻ±äʹMC4Rµ°°×µÚ298λ°±»ùËáÌ춬°±Ëá±»Ì춬õ£°·´úÌæ[49].¶Ô²»Í¬Æ·ÏµÖí¸ÃλµãµÄ¶à̬ÓëÉú²úÐÔÄܹØϵµÄÑо¿£¬Ö¤ÊµÁËMC4R»ùÒòÐÍÓë±³±ìºñ¡¢Éú³¤ÂʺͲÉʳÁ¿³ÊÇ¿Ïà¹Ø[50].ÖíMC4R»ùÒò´æÔÚÒ»¸ö°±»ùËá±àÂëµÄ´íÒåÍ»±ä£¬¿Éµ¼ÖÂÖíëØÌåÖغͲÉʳÁ¿ÏÔ×ű仯[51].

¡¡¡¡×ÛÉÏËùÊö£¬Leptin¡¢UCP3¡¢FoxO1¡¢CAST¡¢MC4R»ùÒò¶ÔÖíµÄÖ¬·¾³Á»ýÓë´úл¾ùÆðÖØÒª×÷Ó᣾¡¹Ü¶ÔÕâЩ»ùÒòµÄ½á¹¹ºÍ±í´ïµ÷¿Ø¹æÂÉÓÐÁËһЩÈÏʶ£¬µ«¾ßÌåµ÷¿Ø»úÀíºÍ·Ö×Ó»úÖÆ»¹ÓдýÓÚ´Óϸ°ûˮƽºÍ·Ö×ÓˮƽÉÏ×÷½øÒ»²½Ñо¿[52].ÁíÍ⣬ϣÍûÔÚ²»¾ÃµÄ½«À´ÄÜÀûÓÃÕâЩÖíÈâÖÊÐÔ×´Ö÷Òª¹¦ÄÜ»ùÒò½øÐÐÈâÖʸÄÁ¼µÈÓýÖÖ¹¤×÷£¬ÎªÓÅÖÊÈâÖÊÐÔ×´µÄÖíÆ·ÖÖµÄÓýÖÖʵ¼ùÌṩÒÀ¾Ý£¬´Ó¶ø»ñµÃ¸ü¸ßÆ·ÖʵÄÖíÈâÀ´Âú×ãÈËÃǵÄÐèÇó[53].
¡¡¡¡
¡¡¡¡²Î¿¼ÎÄÏ×
¡¡¡¡
¡¡¡¡[1] Zhang Y, Proenca R, Maffei M, et al. Position-al cloning of the mouse obese gene and itshuman homologue[J]. J Nature, 1994, 372£¨6505£©£º 425-432.
¡¡¡¡[2] Wauters M, Considine R V, Van Gaal L F. Humanleptin: from a adipocyte hormone to anendo-crine mediator[J]. J Eur J Endocrinology,2000, 143 £¨3£©£º 293-311.
¡¡¡¡[3] Berthoud H R. Interactions between the“cogni-tive” and “metabolic” brain in the controlof food intake[J]. J Physiol Behav, 2007, 91£¨5£©£º 486-98.
¡¡¡¡[4] Halaas J L, Gajiwala K S, Maffei M, et al.Weight-reducing effects of the plasma pro-tein encoded by the obese gene[J]. J Sci-ence, 1995, 269£¨5223£©£º 543-546.
¡¡¡¡[5] Pelleymounter M A, Cullen M J, Baker M B, etal. Effects of the obese gene product onbody weight regulation in ob/ob mice[J]. JScience, 1995, 28, 269£¨5223£©£º 540-543.

Ïà¹Ø±êÇ©£º
  • ±¨¾¯Æ½Ì¨
  • ÍøÂç¼à²ì
  • ±¸°¸ÐÅÏ¢
  • ¾Ù±¨ÖÐÐÄ
  • ´«²¥ÎÄÃ÷
  • ³ÏÐÅÍøÕ¾